New study shows how to protect the brain to prevent depression and cognitive impairment caused by whole brain radiotherapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jun-2026 03:16 ET (22-Jun-2026 07:16 GMT/UTC)
Whole brain radiotherapy (WBRT) saves lives by treating cancer that has spread to the brain, but it also causes long-standing brain damage. Many patients develop memory problems, thinking difficulties, and depression after WBRT. There are currently no medicines that adequately prevent these problems of WBRT. The research team discovered that an experimental neuroprotective drug, P7C3-A20, could protect the brain from these harmful side effects of WBRT in animal models, without impairing the ability of radiation to kill tumor cells. If these findings translate to humans, adding a drug like P7C3-A20 to WBRT could safely and effectively preserve cognition and mood after lifesaving WBRT.
Study to be presented at this year's ESGO 2026 , demonstrates significant overall survival benefit with Elenagen plus Gemcitabine in one of the deadliest gynecologic malignancies
The application of food as a medical intervention is founded on decades of evidence demonstrating that various plant-forward dietary patterns are associated with reduced risk of cardiovascular disease, dementia, type 2 diabetes and cancer, and all-cause mortality, while greater consumption of ultra-processed foods is associated with higher risks of a variety of adverse health outcomes, such as cardiometabolic disease, common mental disorders, and mortality outcomes.
Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer cases, yet remain an understudied group, according to a new review written by UCL (University College London) researchers.
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can recruit immune cells to penetrate and persist deep within brain tumors. The research, which is published in Cell, provides details on how this therapy prolonged survival in patients with glioblastoma, the most common and malignant primary brain tumor, in a recent clinical trial.
(Boston)—Throughout a person’s lifetime, the cells lining the respiratory tract are exposed to inhaled pollutants, including cigarette smoke. These exposures can cause molecular changes that disrupt normal cell behavior, leading to abnormal growth and function. Over time, these airway abnormalities—called bronchial premalignant lesions—can progress to a type of non-small cell lung cancer known as squamous cell carcinoma.
In a new study from Boston University Chobanian & Avedisian School of Medicine, researchers have identified a microRNA (miRNA)—a small non-coding RNA that can suppress gene expression—that is overexpressed in lesions that progress in severity. This miRNA reduces the expression of genes involved in immune recognition, potentially enabling abnormal cells to evade detection by the immune system.
City of Hope Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news, such as recognitions, collaborations and the latest research defining the future of medical treatment. This roundup of six studies highlights new insights into cancer treatment, immune balance and early disease detection.